Senate committee approves amended plan to address price gouging of generic drugs
A Senate committee approved an amended proposal on Tuesday intended to prevent manufacturers and wholesale drug distributors from engaging in price gouging when selling off-patent or generic drugs.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
